We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Targeting Enzyme “Bottleneck” Reveals Novel Anticancer Drug Strategy

News   Jul 23, 2019 | Original story from Emory University

 
Targeting Enzyme “Bottleneck” Reveals Novel Anticancer Drug Strategy
 
 
Advertisement
 

RELATED ARTICLES

Potential Drug Candidates for Difficult-To-Treat Pediatric Leukemia

News

Scientists have shown that two existing drug candidates hold potential as treatments for a deadly acute myeloid leukemia (AML) subtype that is more common in children.

READ MORE

Grandmother's Exposure to DTT May Impact Granddaughter's Health

News

In the first study showing health effects from a toxic environmental chemical over three generations of people, researchers found that young women today may face increased health risks linked to breast cancer due to their grandmothers’ exposure to the banned pesticide DDT.

READ MORE

Fragment Screen Points to New SARS-CoV-2 Inhibitors

News

A crystallographic fragment screen of the Nsp3 Mac1 protein provides a template for how to develop directly-acting antivirals with novel modes of action.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE